US pharma industry seeks R&D policy for India’s pharma sector
Ahead of the Union Budget 2023-24, the US pharma industry has said that India should come out with a research and development policy for its pharmaceutical sector. Union Finance Minister…
Rise in prices of Raw Materials for Pharma industry
The hike in the prices of petroleum products has caused a steep rise in the prices of raw materials required for the pharma industry which faces acute shortage of active pharmaceutical ingredients (APIs)…
Govt Panel To Help Boost Drug Manufacture, Pharma Funding
NEW DELHI : Aiming to boost local manufacture of essential medicines and attract investments in the pharma sector, the government is set to draw up a plan to build a…
Tougher regulatory watch soon be endorsed on Domestic API producers
Active Pharmaceutical Ingredient (API) producers in India, soon going to face tougher stringent quality checks and frequent site inspections in the coming days as poor bio-available products of dubious origin…
Drug regulator plans national digital database of pharma manufacturers
NEW DELHI: India’s drug regulatory body is creating a national digital database of pharmaceutical manufacturers and their medicines so that regulators can be more effective when acting on problems like…
